Dr Randy Herschel Russell, MD | |
1308 Belk Blvd, Oxford, MS 38655-5302 | |
(662) 234-6551 | |
(662) 234-0468 |
Full Name | Dr Randy Herschel Russell |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 1308 Belk Blvd, Oxford, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801834189 | NPI | - | NPPES |
0011095 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 08418 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Randy Herschel Russell, MD 1308 Belk Blvd, Oxford, MS 38655-5302 Ph: (662) 234-6551 | Dr Randy Herschel Russell, MD 1308 Belk Blvd, Oxford, MS 38655-5302 Ph: (662) 234-6551 |
News Archive
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
The increase has ranged from 30 percent to 40 percent, reports ABC News. In California, an estimated 50,000 people picked a health plan in the first week of December. News outlets also reported on the latest developments in Maryland, Oregon and Minnesota.
Federal funding of human embryonic stem cell (hESC) research is now legal in the United States. Chief judge of the US District Court for the District of Columbia Royce Lamberth has ruled on the case Sherley et al. v. Sebelius, in favor of hESC research. This overturns an existing law that prohibits the government from funding research that destroys the embryo.
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.
A team of researchers from EPFL, (Ecole Polytechnique Fidirale de Lausanne), the University of Lausanne, Northwestern University and Tel Aviv Universitybring biology and statistical physics together to answer the question of how molecular chaperones fold, unfold and pull proteins around in the cell.
› Verified 7 days ago
Randy K Richardson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551 | |
Thomas M Tann Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551 | |
Dr. Emily Taylor Graves, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551 | |
Blake A Booth, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1308 Belk Blvd, Oxford, MS 38655 Phone: 662-234-6551 Fax: 662-234-0468 | |
Dr. William Sumners Mayo, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1628 Highway 30 East, Oxford, MS 38655 Phone: 662-234-3937 Fax: 662-234-3898 | |
Dr. James W Rayner, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1308 Belk Blvd, Oxford, MS 38655 Phone: 662-234-6551 | |
Mr. James Byron Shipp, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1628 Highway 30 East, Oxford, MS 38655 Phone: 662-234-3937 Fax: 662-234-3898 |